Moxidectin
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 10mg | ￥454.00 | 现货 | |
| 50mg | ￥1363.00 | 现货 |
特色产品
- 适用于流式细胞仪和荧光显微镜检测
- 准确区分活细胞/凋亡细胞/坏死细胞
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 对细胞无毒性
- 步骤更简单，无需有机溶剂
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
- 优异的扩增效率、可重复性和稳定性
- 卓越的灵敏度和准确性，操作简单
- 优化的缓冲液和T7 RNA聚合酶混合物
- 20 μL反应体系可获得更高的RNA产量
产品描述
Moxidectin is a macrocyclic lactone anthelmintic drug used to control or prevent parasitic worms. Its principal use is veterinary, in animals ranging from cats and dogs to horses and cattle. Moxidectin-susceptible parasites include Strongylus vulgaris in horses and Ostertagia ostertagi in cattle. In 2018, moxidectin was approved by FDA for treating onchocerciasis (river-blindness) caused by the parasitic worm Onchocerca volvulus.
References:
1. Rolfe PF, Dawson KL, Holm-Martin M. Efficacy of moxidectin and other anthelmintics against small strongyles in horses. Australian Veterinary Journal, 1998, 76(5): 332-334.
2. Hubert J, Kerboeuf D, Cardinaud B, et al. Persistent efficacy of topical moxidectin against Dictyocaulus viviparus and Ostertagia ostertagi. Veterinary Parasitology, 1997, 68(1-2): 187-190.
3. Awadzi K, Opoku NO, Attah SK, et al. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLOS Neglected Tropical Diseases, 2014, 8(6): e2953.
产品性质
| 物理外观 | A solid |
| CAS号 | 113507-06-5 |
| 分子式 | C37H53NO8 |
| 分子量 | 639.82 |
| 溶解度 | ≥128 mg/mL in EtOH; ≥129.4 mg/mL in DMSO; ≥3.27 mg/mL in H2O with gentle warming and ultrasonic |
| SMILES | C/C([C@H]([C@H](/C1=N/OC)C)O[C@]2(C1)C[C@](OC([C@@](C=C(C)[C@@H](O)[C@@]3([H])OC/C4=C\C=C\[C@H](C)C5)([H])[C@@]34O)=O)([H])C[C@](C/C=C5\C)([H])O2)=C\C(C)C |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献，APExBIO并未验证，仅供参考)
IC50和靶点
| 生物活性描述 | 莫西菌素（CL301423）是一种口服活性大环内酯类（ML）驱虫药，用于预防和控制心丝虫和蛔虫。莫西菌素在体内也是 BCRP 和 P-glycoprotein (P-gp) 的底物，在 Bcrp1 和 P-gp 的介导下分泌到母乳中并从宿主和寄生虫体内流出。这可能与乳汁中存在化学残留物有关。 |
沪公网安备 31011002003500